Cargando…
Published anti-SARS-CoV-2 in vitro hits share common mechanisms of action that synergize with antivirals
The global efforts in the past year have led to the discovery of nearly 200 drug repurposing candidates for COVID-19. Gaining more insights into their mechanisms of action could facilitate a better understanding of infection and the development of therapeutics. Leveraging large-scale drug-induced ge...
Autores principales: | Xing, Jing, Paithankar, Shreya, Liu, Ke, Uhl, Katie, Li, Xiaopeng, Ko, Meehyun, Kim, Seungtaek, Haskins, Jeremy, Chen, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8344595/ https://www.ncbi.nlm.nih.gov/pubmed/34245241 http://dx.doi.org/10.1093/bib/bbab249 |
Ejemplares similares
-
Published Anti-SARS-CoV-2 In Vitro Hits Share Common Mechanisms of Action that Synergize with Antivirals
por: Xing, Jing, et al.
Publicado: (2021) -
Lancemaside A from Codonopsis lanceolata: Studies on Antiviral Activity and Mechanism of Action against SARS-CoV-2 and Its Variants of Concern
por: Kim, Tai Young, et al.
Publicado: (2022) -
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
por: Jeon, Sangeun, et al.
Publicado: (2020) -
Deciphering COVID-19 host transcriptomic complexity and variations for therapeutic discovery against new variants
por: Xing, Jing, et al.
Publicado: (2022) -
TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351)
por: Lee, Jihye, et al.
Publicado: (2021)